FMP
Cardio Diagnostics Holdings, Inc.
CDIO
NASDAQ
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
0.29 USD
0.0023 (0.793%)
About
ceo
Dr. Meeshanthini V. Dogan Ph.D.
sector
Healthcare
industry
Biotechnology
exchange
NASDAQ
Description
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
CIK
0001870144
ISIN
US14159C1036
CUSIP
14159C103
Address
400 N Aberdeen St
Phone
855 226 9991
Country
US
Employee
7
IPO Date
Jan 14, 2022
Summary
CIK
0001870144
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
14159C103
ISIN
US14159C1036
Country
US
Price
0.29
Beta
4.81
Volume Avg.
233.51k
Market Cap
6.94M
Shares
-
52-Week
0.171-3.56
DCF
-0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.72
P/B
-
Website
https://cardiodiagnosticsinc.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CDIO News
It looks like there's no news available.
